OBLIQUE THERAPEUTICS AB has a total of 77 patent applications. It increased the IP activity by 76.0%. Its first patent ever was published in 2016. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Brazil. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are UCB Biopharma SRL, DEV CT BIOTECHNOLOGY and SAVID THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | Australia | 7 | |
#3 | Brazil | 7 | |
#4 | Canada | 7 | |
#5 | China | 7 | |
#6 | EPO (European Patent Office) | 7 | |
#7 | United Kingdom | 7 | |
#8 | Republic of Korea | 7 | |
#9 | Mexico | 7 | |
#10 | United States | 7 | |
#11 | Israel | 2 | |
#12 | Singapore | 2 | |
#13 | Hong Kong | 1 | |
#14 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Measurement | |
#5 | Foods and drinks | |
#6 | Computer technology | |
#7 | Medical technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Peptides | |
#4 | Analysing materials | |
#5 | Medical preparations | |
#6 | Combinatorial chemistry | |
#7 | Enzymes | |
#8 | Bioinformatics | |
#9 | Measuring microorganism processes | |
#10 | Electrotherapy |
# | Name | Total Patents |
---|---|---|
#1 | Orwar Owe | 33 |
#2 | Stafford William | 28 |
#3 | Pelcman Benjamin | 28 |
#4 | Trkulja Carolina | 26 |
#5 | Davidson Max | 16 |
#6 | Priede Martins | 14 |
#7 | Suna Edgars | 14 |
#8 | Owe Orwar | 9 |
#9 | Benjamin Pelcman | 8 |
#10 | Carolina Trkulja | 8 |
Publication | Filing date | Title |
---|---|---|
GB202101780D0 | Epitopes and Antibodies | |
GB202019522D0 | Epitopes and antibodies | |
GB202002556D0 | Epitopes and antobodies | |
GB201918103D0 | Epitopes and antibodies | |
GB201918104D0 | Epitopes and antibodies | |
WO2018146471A1 | Heterocyclylsulfonyl-substituted pyridines and their use in the treatment of cancer | |
US2020239417A1 | Hydrocarbylsulfonyl-substituted pyridines and their use in the treatment of cancer | |
KR20190115011A | Sulfinylpyridine and its use in the treatment of cancer | |
MX2019009351A | Heteroarylsulfonyl-substituted pyridines and their use in the treatment of cancer. | |
GB201617002D0 | Multi-protease method | |
GB201614884D0 | Method | |
WO2016193403A1 | Electroporation device | |
US2018111990A1 | New methods for epitope selection |